Multinational drug firms eyeing Korean OTC market

Published: 2013-03-06 07:00:00

Updated: 2013-03-06 07:00:00

Korean government’s recent measures to re-categorize drugs has prompted foreign drug makers to renew their efforts to expand into the country’s over the counter (OTC) drug market.

Experts point out that Japanese OTC makers are poised to enter the Korean OTC market as situation will permit.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK